Yehuda Reznick
Director
Yehuda Reznick, 78, brings decades of experience in accounting, auditing, tax and corporate governance. From 1991 to 2014, he served as an audit partner at Kesselman & Kesselman CPA, a member firm of PricewaterhouseCoopers International Limited. Prior to joining Kesselman & Kesselman, Mr. Reznick was a tax and audit partner at Shahak, Peer Reznick CPA for sixteen years. Mr. Reznick currently serves on the board of directors of Oramed Pharmaceuticals Inc. and, since 2019, has also served on the board of directors of Hiron-Trade Investments & Industrial Buildings Ltd. (TASE: HRON). Mr. Reznick previously served on the board of directors of Bonus Biogroup Ltd. (OTC: BBIXF) from 2017 to 2023.
- Member of the Audit Committee
- Member of the Compensation Committee
- Member of the Finance Committee